Christina Ai-Kheng Kim, MD, FRCPC

Research summary

Dr. Christina Ai-Kheng Kim’s research focuses on gastrointestinal cancers, with a particular interest in pancreatic cancer. Her work includes studying real-world treatment patterns, outcomes, and chemotherapy-related toxicity. She is involved in developing and conducting investigator-initiated trials. Recent research has focused on symptom burden in pancreatic cancer and the impact of early palliative care on quality of life. Dr. Kim also leads the hereditary gastrointestinal cancer clinic and is working on a registry for Manitoba patients with Lynch Syndrome.

Brief bio

Dr. Christina Ai-Kheng Kim is an assistant professor of internal medicine at the Max Rady College of Medicine, University of Manitoba. She is the research director for the medical oncology residency program committee and a medical oncologist at CancerCare Manitoba. Born and raised in Alberta, she attended medical school at the University of Manitoba, followed by an internal medicine residency at the University of British Columbia and a medical oncology subspecialty residency at the University of Alberta. Dr. Kim completed a CIHR and CAMO-funded fellowship focusing on pancreatic cancer. She joined CancerCare Manitoba and the University of Manitoba in 2014 and is active in the gastrointestinal and breast disease site groups. Her clinical practice informs her research, and she is dedicated to improving patient care through clinical research.

Cross-appointments

• Assistant professor, Max Rady College of Medicine, University of Manitoba
• Medical oncologist, CancerCare Manitoba

Education

• Medical oncology clinical and research fellow (2014)
• Medical oncology certification (2013)
• Internal medicine certification (2010)
• Doctor of Medicine (MD) (2007)

Awards

2019

• Medical Oncology & Hematology Excellence in Research Award